Vivo Opportunity Fund Holdings, L.P. - Sep 30, 2025 SCHEDULE 13G Report for Compass Therapeutics, Inc. Common Stock, par value $0.0001 per share (CMPX)

Filing Manager
Vivo Opportunity Fund Holdings, L.P.
Reporting Manager
Vivo Opportunity Fund Holdings, L.P.
Security
Compass Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
CMPX
Shares outstanding
176M shares
Disclosed Ownership
9M shares
Ownership
5.1%
Form type
SCHEDULE 13G
Date filed
11/14/2025, 06:35 PM
Date of event
Sep 30, 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Vivo Opportunity Fund Holdings, L.P. 5.1% 9M 9M 0 /s/ Kevin Dai Kevin Dai/Managing Member of Vivo Opportunity, LLC, General Partner
Vivo Opportunity, LLC 5.1% 9M 9M 0 /s/ Kevin Dai Kevin Dai/Managing Member
Vivo Opportunity Cayman Fund, L.P. 0.3% 549K 549K 0 /s/ Kevin Dai Kevin Dai/Managing Member of Vivo Opportunity Cayman, LLC, General Partner
Vivo Opportunity Cayman, LLC 0.3% 549K 549K 0 /s/ Kevin Dai Kevin Dai/Managing Member